Literature DB >> 23080273

Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression.

Sarah N Dowey1, Xiaosong Huang, Bin-Kuan Chou, Zhaohui Ye, Linzhao Cheng.   

Abstract

Several human postnatal somatic cell types have been successfully reprogrammed to induced pluripotent stem cells (iPSCs). Blood mononuclear cells (MNCs) offer several advantages compared with other cell types. They are easily isolated from umbilical cord blood (CB) or adult peripheral blood (PB), and can be used fresh or after freezing. A short culture allows for more efficient reprogramming, with iPSC colonies forming from blood MNCs in 14 d, compared with 28 d for age-matched fibroblastic cells. The advantages of briefly cultured blood MNCs may be due to favorable epigenetic profiles and gene expression patterns. Blood cells from adults, especially nonlymphoid cells that are replenished frequently from intermittently activated blood stem cells, are short-lived in vivo and may contain less somatic mutations than skin fibroblasts, which are more exposed to environmental mutagens over time. We describe here a detailed, validated protocol for effective generation of integration-free human iPSCs from blood MNCs by plasmid vectors.

Entities:  

Mesh:

Year:  2012        PMID: 23080273      PMCID: PMC3756815          DOI: 10.1038/nprot.2012.121

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  31 in total

1.  Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells.

Authors:  Deepa Subramanyam; Samy Lamouille; Robert L Judson; Jason Y Liu; Nathan Bucay; Rik Derynck; Robert Blelloch
Journal:  Nat Biotechnol       Date:  2011-04-13       Impact factor: 54.908

2.  Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.

Authors:  Prashant Mali; Zhaohui Ye; Holly H Hommond; Xiaobing Yu; Jeff Lin; Guibin Chen; Jizhong Zou; Linzhao Cheng
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

3.  Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.

Authors:  Tomohisa Seki; Shinsuke Yuasa; Keiichi Fukuda
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

4.  Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines.

Authors:  Chunlin Zou; Bin-Kuan Chou; Sarah N Dowey; Kitman Tsang; Xiaosong Huang; Cyndi F Liu; Cory Smith; Jonathan Yen; Prashant Mali; Yu Alex Zhang; Linzhao Cheng; Zhaohui Ye
Journal:  Stem Cells Dev       Date:  2012-02-15       Impact factor: 3.272

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

9.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Authors:  Trond Aasen; Angel Raya; Maria J Barrero; Elena Garreta; Antonella Consiglio; Federico Gonzalez; Rita Vassena; Josipa Bilić; Vladimir Pekarik; Gustavo Tiscornia; Michael Edel; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Biotechnol       Date:  2008-10-17       Impact factor: 54.908

10.  Chemically defined conditions for human iPSC derivation and culture.

Authors:  Guokai Chen; Daniel R Gulbranson; Zhonggang Hou; Jennifer M Bolin; Victor Ruotti; Mitchell D Probasco; Kimberly Smuga-Otto; Sara E Howden; Nicole R Diol; Nicholas E Propson; Ryan Wagner; Garrett O Lee; Jessica Antosiewicz-Bourget; Joyce M C Teng; James A Thomson
Journal:  Nat Methods       Date:  2011-04-10       Impact factor: 28.547

View more
  76 in total

1.  Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.

Authors:  Faith A Bazley; Cyndi F Liu; Xuan Yuan; Haiping Hao; Angelo H All; Alejandro De Los Angeles; Elias T Zambidis; John D Gearhart; Candace L Kerr
Journal:  Stem Cells Dev       Date:  2015-08-10       Impact factor: 3.272

2.  Engineering bone tissue substitutes from human induced pluripotent stem cells.

Authors:  Giuseppe Maria de Peppo; Iván Marcos-Campos; David John Kahler; Dana Alsalman; Linshan Shang; Gordana Vunjak-Novakovic; Darja Marolt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-07       Impact factor: 11.205

Review 3.  Concise review: modeling central nervous system diseases using induced pluripotent stem cells.

Authors:  Xianmin Zeng; Joshua G Hunsberger; Anton Simeonov; Nasir Malik; Ying Pei; Mahendra Rao
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

4.  Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.

Authors:  Ras Trokovic; Jere Weltner; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Veikko Salomaa; Anu Jalanko; Timo Otonkoski; Aija Kyttälä
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

Review 5.  Methods of induced pluripotent stem cells for clinical application.

Authors:  Tomohisa Seki; Keiichi Fukuda
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 6.  Looking to the future following 10 years of induced pluripotent stem cell technologies.

Authors:  Mo Li; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2016-08-04       Impact factor: 13.491

7.  Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration.

Authors:  Jiang Hu; Yongyu Wang; Jiao Jiao; Zhongning Liu; Chao Zhao; Zhou Zhou; Zhanpeng Zhang; Kaitlynn Forde; Lunchang Wang; Jiangang Wang; David J Baylink; Xiao-Bing Zhang; Shaorong Gao; Bo Yang; Y Eugene Chen; Peter X Ma
Journal:  Biomaterials       Date:  2015-09-11       Impact factor: 12.479

8.  The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.

Authors:  Xinxiu Liu; Jiayu Chen; Wenchao Liu; Xiaogang Li; Qi Chen; Tao Liu; Shaorong Gao; Min Deng
Journal:  Neurogenetics       Date:  2015-04-26       Impact factor: 2.660

Review 9.  Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

Authors:  Zhiguo Chen
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

10.  Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes.

Authors:  Sandy S C Hung; Alice Pébay; Raymond C B Wong
Journal:  J Vis Exp       Date:  2015-08-20       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.